Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Hyaluronate and Sodium Bromide for Glaucoma-Induced Dry Eye
NCT03515187Phase 3Unknown
- Sponsor
- Southern Medical University Shenzhen Hospital
- Start
- Jun 2018
- Primary completion
- Apr 2021
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Aili, sodium bromide in dry eye syndrome (DED), meibomian gland dysfunction (MGD), sponsored by Southern Medical University Shenzhen Hospital. Status: unknown.
02
Drugs
Ailisodium bromide
03
Conditions
dry eye syndrome (DED)meibomian gland dysfunction (MGD)
Beyond the preview
Go deeper on NCT03515187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03515187.